| OVX | 表記: | 1-(3-chlorophenyl)-4-(isoquinoline-4-carbonyl)piperazin-2-one | 組成式: | C20 H16 Cl N3 O2 | SMILES: | O=C(c1cncc2ccccc21)N1CC(=O)N(CC1)c1cccc(Cl)c1 | InChi: | InChI=1S/C20H16ClN3O2/c21-15-5-3-6-16(10-15)24-9-8-23(13-19(24)25)20(26)18-12-22-11-14-4-1-2-7-17(14)18/h1-7,10-12H,8-9,13H2 | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | 1-(3-chlorophenyl)-4-(isoquinoline-4-carbonyl)piperazin-2-one |
|
| BBS | 表記: | 4-TERT-BUTYLBENZENESULFONIC ACID | 組成式: | C10 H14 O3 S | SMILES: | O=S(=O)(O)c1ccc(cc1)C(C)(C)C | InChi: | InChI=1S/C10H14O3S/c1-10(2,3)8-4-6-9(7-5-8)14(11,12)13/h4-7H,1-3H3,(H,11,12,13) | 定義日: | 2000-03-31 | 最終更新日: | 2023-11-03 | 識別子(ID): | 4-tert-butylbenzenesulfonic acid |
|
| OWC | 表記: | (3S)-3-(3-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one | 組成式: | C20 H17 Cl N2 O | SMILES: | Clc1cccc(c1)C1CCCN(c2cncc3ccccc23)C1=O | InChi: | InChI=1S/C20H17ClN2O/c21-16-7-3-6-14(11-16)18-9-4-10-23(20(18)24)19-13-22-12-15-5-1-2-8-17(15)19/h1-3,5-8,11-13,18H,4,9-10H2/t18-/m0/s1 | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | (3S)-3-(3-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one |
|
| OWX | 表記: | 2-(3-chlorophenyl)-N-(1,2,3,4-tetrahydro-1,7-naphthyridin-5-yl)acetamide | 組成式: | C16 H16 Cl N3 O | SMILES: | Clc1cccc(c1)CC(=O)Nc1cncc2NCCCc12 | InChi: | InChI=1S/C16H16ClN3O/c17-12-4-1-3-11(7-12)8-16(21)20-15-10-18-9-14-13(15)5-2-6-19-14/h1,3-4,7,9-10,19H,2,5-6,8H2,(H,20,21) | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | 2-(3-chlorophenyl)-N-(1,2,3,4-tetrahydro-1,7-naphthyridin-5-yl)acetamide |
|
| BCS | 表記: | BENZYLCYSTEINE | 組成式: | C10 H13 N O2 S | SMILES: | O=C(O)C(N)CSCc1ccccc1 | InChi: | InChI=1S/C10H13NO2S/c11-9(10(12)13)7-14-6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2023-11-03 | 識別子(ID): | S-benzyl-L-cysteine |
|
| OXJ | 表記: | 1-[3,5-bis(trifluoromethyl)phenyl]-N-methylmethanamine | 組成式: | C10 H9 F6 N | SMILES: | CNCc1cc(cc(c1)C(F)(F)F)C(F)(F)F | InChi: | InChI=1S/C10H9F6N/c1-17-5-6-2-7(9(11,12)13)4-8(3-6)10(14,15)16/h2-4,17H,5H2,1H3 | 定義日: | 2019-07-15 | 最終更新日: | 2023-11-03 | 公開日: | 2019-12-11 | 識別子(ID): | 1-[3,5-bis(trifluoromethyl)phenyl]-N-methylmethanamine |
|
| OYF | 表記: | (4R)-6-chloro-N-(2,7-naphthyridin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide | 組成式: | C18 H14 Cl N3 O2 | SMILES: | Clc1ccc2OCCC(c2c1)C(=O)Nc1cncc2cnccc21 | InChi: | InChI=1S/C18H14ClN3O2/c19-12-1-2-17-15(7-12)14(4-6-24-17)18(23)22-16-10-21-9-11-8-20-5-3-13(11)16/h1-3,5,7-10,14H,4,6H2,(H,22,23)/t14-/m1/s1 | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | (4R)-6-chloro-N-(2,7-naphthyridin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide |
|
| OYX | 表記: | N-(2-cyclohexylethyl)-2-(isoquinolin-4-yl)-N-[(thiophen-2-yl)methyl]acetamide | 組成式: | C24 H28 N2 O S | SMILES: | O=C(Cc1cncc2ccccc21)N(CCC1CCCCC1)Cc1cccs1 | InChi: | InChI=1S/C24H28N2OS/c27-24(15-21-17-25-16-20-9-4-5-11-23(20)21)26(18-22-10-6-14-28-22)13-12-19-7-2-1-3-8-19/h4-6,9-11,14,16-17,19H,1-3,7-8,12-13,15,18H2 | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | N-(2-cyclohexylethyl)-2-(isoquinolin-4-yl)-N-[(thiophen-2-yl)methyl]acetamide |
|
| OZC | 表記: | (3S)-3-(4-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one | 組成式: | C20 H17 Cl N2 O | SMILES: | Clc1ccc(cc1)C1CCCN(c2cncc3ccccc23)C1=O | InChi: | InChI=1S/C20H17ClN2O/c21-16-9-7-14(8-10-16)18-6-3-11-23(20(18)24)19-13-22-12-15-4-1-2-5-17(15)19/h1-2,4-5,7-10,12-13,18H,3,6,11H2/t18-/m0/s1 | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | (3S)-3-(4-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one |
|
| BF6 | 表記: | [(4Z)-2-(aminomethyl)-4-{[4-(benzenecarbonyl)phenyl]methylidene}-5-oxo-4,5-dihydro-1H-imidazol-1-yl]acetic acid | 組成式: | C20 H17 N3 O4 | SMILES: | C(=C1N=C(CN)N(CC(O)=O)C1=O)c3ccc(C(c2ccccc2)=O)cc3 | InChi: | InChI=1S/C20H17N3O4/c21-11-17-22-16(20(27)23(17)12-18(24)25)10-13-6-8-15(9-7-13)19(26)14-4-2-1-3-5-14/h1-10H,11-12,21H2,(H,24,25)/b16-10- | 別名: | PEPTIDE DERIVED CHROMOPHORE | 定義日: | 2018-12-20 | 最終更新日: | 2023-11-03 | 公開日: | 2019-01-30 | 識別子(ID): | [(4Z)-2-(aminomethyl)-4-{[4-(benzenecarbonyl)phenyl]methylidene}-5-oxo-4,5-dihydro-1H-imidazol-1-yl]acetic acid |
|
| OZW | 表記: | phenylhydrazinyl phenylalanine | 組成式: | C15 H17 N3 O2 | SMILES: | N[CH](Cc1ccc(NNc2ccccc2)cc1)C(O)=O | InChi: | InChI=1S/C15H17N3O2/c16-14(15(19)20)10-11-6-8-13(9-7-11)18-17-12-4-2-1-3-5-12/h1-9,14,17-18H,10,16H2,(H,19,20)/t14-/m0/s1 | 定義日: | 2020-04-13 | 最終更新日: | 2023-11-03 | 公開日: | 2020-07-22 | 識別子(ID): | (2~{S})-2-azanyl-3-[4-(2-phenylhydrazinyl)phenyl]propanoic acid |
|
| BF9 | 表記: | [(4Z)-2-[(1R,2S)-1-amino-2-hydroxypropyl]-4-{[4-(benzenecarbonyl)phenyl]methylidene}-5-oxo-4,5-dihydro-1H-imidazol-1-yl]acetic acid | 組成式: | C22 H21 N3 O5 | SMILES: | c1ccccc1C(c3ccc(C=C2C(N(C(C(C(O)C)N)=N2)CC(=O)O)=O)cc3)=O | InChi: | InChI=1S/C22H21N3O5/c1-13(26)19(23)21-24-17(22(30)25(21)12-18(27)28)11-14-7-9-16(10-8-14)20(29)15-5-3-2-4-6-15/h2-11,13,19,26H,12,23H2,1H3,(H,27,28)/b17-11-/t13-,19-/m0/s1 | 別名: | PEPTIDE DERIVED CHROMOPHORE | 定義日: | 2018-12-19 | 最終更新日: | 2023-11-03 | 公開日: | 2019-01-30 | 識別子(ID): | [(4Z)-2-[(1R,2S)-1-amino-2-hydroxypropyl]-4-{[4-(benzenecarbonyl)phenyl]methylidene}-5-oxo-4,5-dihydro-1H-imidazol-1-yl]acetic acid |
|
| OZX | 表記: | 2-(6-chloropyridin-2-yl)-N-(isoquinolin-4-yl)acetamide | 組成式: | C16 H12 Cl N3 O | SMILES: | Clc1cccc(CC(=O)Nc2cncc3ccccc32)n1 | InChi: | InChI=1S/C16H12ClN3O/c17-15-7-3-5-12(19-15)8-16(21)20-14-10-18-9-11-4-1-2-6-13(11)14/h1-7,9-10H,8H2,(H,20,21) | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | 2-(6-chloropyridin-2-yl)-N-(isoquinolin-4-yl)acetamide |
|
| P0X | 表記: | 4-[4-(3-chlorophenyl)-3-oxopiperazine-1-carbonyl]quinolin-2(1H)-one | 組成式: | C20 H16 Cl N3 O3 | SMILES: | O=C(C1=CC(=O)Nc2ccccc21)N1CC(=O)N(CC1)c1cccc(Cl)c1 | InChi: | InChI=1S/C20H16ClN3O3/c21-13-4-3-5-14(10-13)24-9-8-23(12-19(24)26)20(27)16-11-18(25)22-17-7-2-1-6-15(16)17/h1-7,10-11H,8-9,12H2,(H,22,25) | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | 4-[4-(3-chlorophenyl)-3-oxopiperazine-1-carbonyl]quinolin-2(1H)-one |
|
| P1V | 表記: | (2~{S})-2-azanyl-6-(5-methyl-1~{H}-1,2,4-triazol-3-yl)hexanoic acid | 組成式: | C9 H16 N4 O2 | SMILES: | Cc1[nH]nc(CCCC[CH](N)C(O)=O)n1 | InChi: | InChI=1S/C9H16N4O2/c1-6-11-8(13-12-6)5-3-2-4-7(10)9(14)15/h7H,2-5,10H2,1H3,(H,14,15)(H,11,12,13)/t7-/m0/s1 | 定義日: | 2022-09-29 | 最終更新日: | 2023-11-03 | 公開日: | 2023-01-11 | 識別子(ID): | (2~{S})-2-azanyl-6-(5-methyl-1~{H}-1,2,4-triazol-3-yl)hexanoic acid |
|
| 4PQ | 表記: | 5-hydroxy-L-tryptophan | 組成式: | C11 H12 N2 O3 | SMILES: | NC(C(=O)O)Cc1cnc2ccc(cc12)O | InChi: | InChI=1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)/t9-/m0/s1 | 別名: | Oxitriptan | 定義日: | 2015-05-01 | 最終更新日: | 2023-11-03 | 公開日: | 2017-01-11 | 識別子(ID): | 5-hydroxy-L-tryptophan |
|
| P2Q | 表記: | 2-hydroxy-5-{[(1S,2E)-1-formyl-4-phenoxybut-2-en-1yl]amino}-L-tyrosine | 組成式: | C20 H22 N2 O6 | SMILES: | N[CH](Cc1cc(N[CH](C=O)C=CCOc2ccccc2)c(O)cc1O)C(O)=O | InChi: | InChI=1S/C20H22N2O6/c21-16(20(26)27)9-13-10-17(19(25)11-18(13)24)22-14(12-23)5-4-8-28-15-6-2-1-3-7-15/h1-7,10-12,14,16,22,24-25H,8-9,21H2,(H,26,27)/b5-4+/t14-,16-/m0/s1 | 別名: | 3-{[(1S,2E)-1-formyl-4-phenoxybut-2-en-1-yl]amino}-6-hydroxy-L-tyrosine | 定義日: | 2009-11-10 | 最終更新日: | 2023-11-03 | 識別子(ID): | (2S)-2-azanyl-3-[2,4-dihydroxy-5-[[(E,2S)-1-oxo-5-phenoxy-pent-3-en-2-yl]amino]phenyl]propanoic acid |
|
| 4QK | 表記: | 6-[4-(2-aminoethyl)-1H-1,2,3-triazol-1-yl]-L-norleucine | 組成式: | C10 H19 N5 O2 | SMILES: | NC(CCCCn1cc(CCN)nn1)C(O)=O | InChi: | InChI=1S/C10H19N5O2/c11-5-4-8-7-15(14-13-8)6-2-1-3-9(12)10(16)17/h7,9H,1-6,11-12H2,(H,16,17)/t9-/m0/s1 | 定義日: | 2016-07-19 | 最終更新日: | 2023-11-03 | 公開日: | 2016-09-21 | 識別子(ID): | 6-[4-(2-aminoethyl)-1H-1,2,3-triazol-1-yl]-L-norleucine |
|
| P3L | 表記: | (4R)-6-chloro-N-[(4R)-2-oxopiperidin-4-yl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide | 組成式: | C15 H17 Cl N2 O3 | SMILES: | O=C1CC(CCN1)NC(=O)C1CCOc2ccc(Cl)cc21 | InChi: | InChI=1S/C15H17ClN2O3/c16-9-1-2-13-12(7-9)11(4-6-21-13)15(20)18-10-3-5-17-14(19)8-10/h1-2,7,10-11H,3-6,8H2,(H,17,19)(H,18,20)/t10-,11-/m1/s1 | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | (4R)-6-chloro-N-[(4R)-2-oxopiperidin-4-yl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide |
|
| P3Q | 表記: | 2-hydroxy-5-{[(1E)-1-(2-oxoethylidene)-4-phenylbutyl]amino}-L-tyrosine | 組成式: | C21 H24 N2 O5 | SMILES: | N[CH](Cc1cc(NC(CCCc2ccccc2)=CC=O)c(O)cc1O)C(O)=O | InChi: | InChI=1S/C21H24N2O5/c22-17(21(27)28)11-15-12-18(20(26)13-19(15)25)23-16(9-10-24)8-4-7-14-5-2-1-3-6-14/h1-3,5-6,9-10,12-13,17,23,25-26H,4,7-8,11,22H2,(H,27,28)/b16-9+/t17-/m0/s1 | 定義日: | 2009-11-19 | 最終更新日: | 2023-11-03 | 識別子(ID): | (2S)-2-azanyl-3-[2,4-dihydroxy-5-[[(E)-1-oxo-6-phenyl-hex-2-en-3-yl]amino]phenyl]propanoic acid |
|
| P4E | 表記: | (2S,4E)-2-amino-5-phenylpent-4-enoic acid | 組成式: | C11 H13 N O2 | SMILES: | O=C(O)C(N)C/C=C/c1ccccc1 | InChi: | InChI=1S/C11H13NO2/c12-10(11(13)14)8-4-7-9-5-2-1-3-6-9/h1-7,10H,8,12H2,(H,13,14)/b7-4+/t10-/m0/s1 | 定義日: | 2011-10-13 | 最終更新日: | 2023-11-03 | 識別子(ID): | (2S,4E)-2-amino-5-phenylpent-4-enoic acid |
|
| P4R | 表記: | (1'M,4S)-6-chloro-1'-(isoquinolin-4-yl)-2,3-dihydrospiro[[1]benzopyran-4,4'-imidazolidine]-2',5'-dione | 組成式: | C20 H14 Cl N3 O3 | SMILES: | Clc1ccc2OCCC3(NC(=O)N(C3=O)c3cncc4ccccc43)c2c1 | InChi: | InChI=1S/C20H14ClN3O3/c21-13-5-6-17-15(9-13)20(7-8-27-17)18(25)24(19(26)23-20)16-11-22-10-12-3-1-2-4-14(12)16/h1-6,9-11H,7-8H2,(H,23,26)/t20-/m0/s1 | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | (1'M,4S)-6-chloro-1'-(isoquinolin-4-yl)-2,3-dihydrospiro[[1]benzopyran-4,4'-imidazolidine]-2',5'-dione |
|
| P6O | 表記: | (4S)-6-chloro-4-hydroxy-N-(isoquinolin-4-yl)-2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxamide | 組成式: | C19 H14 Cl N3 O3 | SMILES: | Clc1ccc2NC(=O)CC(O)(c2c1)C(=O)Nc1cncc2ccccc21 | InChi: | InChI=1S/C19H14ClN3O3/c20-12-5-6-15-14(7-12)19(26,8-17(24)22-15)18(25)23-16-10-21-9-11-3-1-2-4-13(11)16/h1-7,9-10,26H,8H2,(H,22,24)(H,23,25)/t19-/m0/s1 | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | (4S)-6-chloro-4-hydroxy-N-(isoquinolin-4-yl)-2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxamide |
|
| P7R | 表記: | (4R)-6-chloro-N-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]pyridin-7-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide | 組成式: | C17 H15 Cl N4 O3 | SMILES: | CN1c2c(NC1=O)cncc2NC(=O)C1CCOc2ccc(Cl)cc21 | InChi: | InChI=1S/C17H15ClN4O3/c1-22-15-12(7-19-8-13(15)21-17(22)24)20-16(23)10-4-5-25-14-3-2-9(18)6-11(10)14/h2-3,6-8,10H,4-5H2,1H3,(H,20,23)(H,21,24)/t10-/m1/s1 | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | (4R)-6-chloro-N-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]pyridin-7-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide |
|
| P9O | 表記: | (4R)-6-chloro-N-(5,6,7,8-tetrahydro-2,6-naphthyridin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide | 組成式: | C18 H18 Cl N3 O2 | SMILES: | Clc1ccc2OCCC(c2c1)C(=O)Nc1cncc2CCNCc21 | InChi: | InChI=1S/C18H18ClN3O2/c19-12-1-2-17-14(7-12)13(4-6-24-17)18(23)22-16-10-21-8-11-3-5-20-9-15(11)16/h1-2,7-8,10,13,20H,3-6,9H2,(H,22,23)/t13-/m1/s1 | 定義日: | 2023-08-18 | 最終更新日: | 2023-11-03 | 公開日: | 2023-11-08 | 識別子(ID): | (4R)-6-chloro-N-(5,6,7,8-tetrahydro-2,6-naphthyridin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide |
|